Invention Publication
- Patent Title: CRYSTALLINE FORM OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDE, PREPARATION, AND USES THEREOF
-
Application No.: US18381767Application Date: 2023-10-19
-
Publication No.: US20240059699A1Publication Date: 2024-02-22
- Inventor: Zhiwei WANG , Yunhang GUO , Gongyin SHI
- Applicant: BEIGENE SWITZERLAND GMBH
- Applicant Address: CH Basel
- Assignee: BEIGENE SWITZERLAND GMBH
- Current Assignee: BEIGENE SWITZERLAND GMBH
- Current Assignee Address: CH Basel
- Priority: WO TCN2016095510 2016.08.16
- The original application number of the division: US17858827 2022.07.06
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61P35/02 ; A61P35/04
![CRYSTALLINE FORM OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDE, PREPARATION, AND USES THEREOF](/abs-image/US/2024/02/22/US20240059699A1/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to a crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide for inhibiting Btk, methods of preparation thereof and pharmaceutical compositions, and use of the crystalline form above in the treatment of a disease, or in the manufacturing of a medicament for the treatment of a disease.
Public/Granted literature
Information query